215
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Level of CD 20-expression and Efficacy of Rituximab Treatment in Patients with Resistant or Relapsing B-cell Prolymphocytic Leukemia and B-cell Chronic Lymphocytic Leukemia

, , , &
Pages 149-151 | Published online: 01 Jul 2009

  • McLaughlin, P., Grill-Lopez, A.J., Link, B.K., Levy, R., Czuczman, M.S., Williams, M.E., Heyman, M.R., Bence-Bruckler, I., White, C.A., Cabanillas, F., Jain, V., Ho, A.D., Lister, J., Wey, K., Shen, D. and Dallaire, B.K. (1998) "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program", J. Clin. Oncol. 16(8), 2825-2833.
  • D'Arena, G., Pellegrin, M., Cascavilla, N., Dell'Olio, M., Di Renzo, N. and Carotenuto, M. (2000) "Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders", Am.J. Hematol. 64, 275-281.
  • Winkler, U., Jensen, M., Manzke, O., Schulz, H., Diehl, V. and Engert, A. (1999) "Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD 20 monoclonal antibody (Rituximab, IDEC-C2B8)", Blood 94(7), 2217-2224.
  • Ladetto, M., Bergui, L., Ricca, I., Campana, S., Pileri, A. and Tarella, C. (2000) "Rituximab anti-CD 20 monoclonal antibody induces marked but transient reduction of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients", Med. Oncol. 17, 203-210.
  • Cheson, B.D. (1996) "National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment", Blood 87, 4990-4997.
  • Fruehauf, S., Topaly, J., Wilmes, A. and Ho, A.D. (2000) "Durchflusszytometrische Diagnostik maligner hämatologischer Erkrankungen", In: Zeller, W.J. and zur Hausen, H., eds, Onkologie (Ecomed, Landsberg/Lech), Chapter II-4, pp 1-32.
  • Ginaldi, L., Martinis, M., Matutes, E., Farahat, N., Morilla, R. and Catovsky, D. (1998) "Levels of expression of CD 19 and CD 20 in chronic B-cell leukaemias", J. Clin. Pathol. 51(5), 364-369.
  • Herold, M., Schulze, A., Härtwig, K. and Anger, G. (2000) "Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab", Ann. Hematol. 79, 332-335.
  • Drapkin, R. (2000) "Pentostatin and rituximab in the treatment of patients with B-cell malignancies", Oncology 14(6), 25-29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.